| __timestamp | MannKind Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100244000 | 1271353000 |
| Thursday, January 1, 2015 | 29674000 | 1620577000 |
| Friday, January 1, 2016 | 14917000 | 2052295000 |
| Sunday, January 1, 2017 | 14118000 | 2075142000 |
| Monday, January 1, 2018 | 8737000 | 2186100000 |
| Tuesday, January 1, 2019 | 6900000 | 3036600000 |
| Wednesday, January 1, 2020 | 6248000 | 2735000000 |
| Friday, January 1, 2021 | 12312000 | 2908100000 |
| Saturday, January 1, 2022 | 19721000 | 3592500000 |
| Sunday, January 1, 2023 | 31283000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Cracking the code
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Regeneron Pharmaceuticals, Inc. and MannKind Corporation offer a fascinating study in contrasts when it comes to research and development (R&D) spending. Over the past decade, Regeneron has consistently invested heavily in R&D, with expenditures growing from approximately $1.3 billion in 2014 to a staggering $4.4 billion in 2023. This represents a remarkable 250% increase, underscoring their commitment to innovation.
In contrast, MannKind Corporation's R&D spending has been more modest, peaking at around $100 million in 2014 but dropping significantly in subsequent years. By 2023, their R&D expenses were approximately $31 million, a 69% decrease from their peak. This disparity highlights the different strategic priorities of these two companies, with Regeneron clearly prioritizing innovation as a cornerstone of their business strategy.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Perrigo Company plc
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs MannKind Corporation